SAGE Therapeutics — CNS Disorders

[Nick47]

The study is currently in Phase 2,

@Nes, is it?

 

[Nes]

Where have I heard that before?

5 to 10 years IF things go well, of course, because it might also never happen

@Nes, is it?

Apparently it is.

Although, given the very small number of participants, it might be considered an early Phase 2 or Phase 2a.

 

[Nick47]

Apparently it is.

Although, given the very small number of participants, it might be considered an early Phase 2 or Phase 2a.

@Nes, no, this is the current completed Phase 2 study.